Content Details
S. 822 (IS) - Scientific External Process for Educated Review of Therapeutics Act of 2025
- Category
- Bills and Statutes
- Collection
- Congressional Bills
- SuDoc Class Number
- Y 1.6:
Y 1.4/1:
- Congress Number
- 119th Congress
- Congress Session
- 1st Session
- Last Action Date Listed
- March 3, 2025
- Action
- Ms. Klobuchar (for herself and Mr. Wicker) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
- Bill Number
- S. 822
- Bill Version
- Introduced in Senate (IS)
- Short Title
- Scientific External Process for Educated Review of Therapeutics Act of 2025
- Full Title
- To amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.
- Sponsors
- Amy Klobuchar(MN)
- Cosponsors
- Roger F. Wicker (MS)
- Committees
- Committee on Health, Education, Labor, and Pensions (Standing)
- United States Code References
- 5 U.S.C. 552(b)
21 U.S.C. 301 and 379dd
- Sponsor:
- Klobuchar, Amy
- Committee Assignment:
- Senate Committee on Health, Education, Labor, and Pensions
| Version | Links related document details | |
|---|---|---|
| 03/03/2025 | Introduced in Senate (is) | details |
Loading...
Loading...